KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to -$4.6 billion.

  • Novavax's Retained Earnings rose 693.56% to -$4.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 billion, marking a year-over-year increase of 693.56%. This contributed to the annual value of -$5.0 billion for FY2024, which is 388.93% down from last year.
  • According to the latest figures from Q3 2025, Novavax's Retained Earnings is -$4.6 billion, which was up 693.56% from -$4.4 billion recorded in Q2 2025.
  • Over the past 5 years, Novavax's Retained Earnings peaked at -$2.1 billion during Q1 2021, and registered a low of -$5.0 billion during Q4 2024.
  • For the 5-year period, Novavax's Retained Earnings averaged around -$4.1 billion, with its median value being -$4.5 billion (2025).
  • As far as peak fluctuations go, Novavax's Retained Earnings crashed by 9303.98% in 2021, and later surged by 963.46% in 2025.
  • Over the past 5 years, Novavax's Retained Earnings (Quarter) stood at -$3.6 billion in 2021, then decreased by 18.19% to -$4.3 billion in 2022, then fell by 12.75% to -$4.8 billion in 2023, then fell by 3.89% to -$5.0 billion in 2024, then increased by 8.44% to -$4.6 billion in 2025.
  • Its last three reported values are -$4.6 billion in Q3 2025, -$4.4 billion for Q2 2025, and -$4.5 billion during Q1 2025.